TOP Classes Of Biologics With 2006 Sales Of US$ 63.8 Bln
Mon, 26 Feb 2007 05:00 PM EST
... The Business Intelligence firm La Merie S.L. reported today that the major cancer antibodies Rituxan, Herceptin, Avastin and Erbitux represent the no. 2 class of top selling biologics with the hightest growth rate of 57 % and combined 2006 sales of US$ 10.6 bln. In contrast, the class of erythropoietin products still had the highest sales in 2006 with US$ 11. [click link for full article] ...
Related Topics
- Travel Destinations
- Zaleplon
- Drug and Medical Device Safety
- Weakness of the back bones at the top of the neck
- VRE
- Choline Salicylate and Magnesium Salicylate
- Lead
- Working Mothers
- Leuprolide Implant
- Pneumococcal Polyvalent Vaccine
- Amlodipine and Atorvastatin
- CEA
- Parenting
- Alfalfa
- Hospital
- Water Safety
- Research
- Health Facilities
- Anger Management
- Understanding Medical Research

Not Signed In -

